InvestorsHub Logo
Followers 49
Posts 5072
Boards Moderated 0
Alias Born 03/23/2014

Re: Rkmatters post# 56898

Tuesday, 03/15/2016 5:44:20 PM

Tuesday, March 15, 2016 5:44:20 PM

Post# of 704328
I don't think your guess is correct.

This is what I just found after some more digging:

http://www.investing.businessweek.wallst.com/research/stocks/financials/drawFiling.asp?docKey=137-000114420414031414-0KVCHMEL0P0FOFQEGT6KJOGI4G&docFormat=HTM&formType=10-Q
includes:

Item 6. Exhibits

10.40* DCVax®-L Manufacturing and Services Agreement, dated January 17, 2014, by and between Northwest Biotherapeutics, Inc. and Cognate BioServices, Inc.

10.41* DCVax®-Direct Manufacturing and Services Agreement, dated January 17, 2014, by and between Northwest Biotherapeutics, Inc. and Cognate BioServices, Inc.

10.42* Ancillary Services Agreement, dated January 17, 2014, by and between Northwest Biotherapeutics, Inc. and Cognate BioServices, Inc.

10.43* Manufacturing Expansion Services Agreement, dated January 17, 2014, by and between Northwest Biotherapeutics, Inc. and Cognate BioServices, Inc.


31.1 Certification of President (Principal Executive Officer and Principal Financial and Accounting Officer), Pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1 Certification of President, Chief Executive Officer and Principal Financial and Accounting Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

* Confidential treatment has been requested with respect to portions of this exhibit. Those portions have been omitted and filed separately with the SEC.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News